The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
about
Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levelsZiv-aflibercept use in metastatic colorectal cancer.Macular oedema in idiopathic macular telangiectasia type 1 responsive to aflibercept but not bevacizumab.Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity.
P2860
The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@ast
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@en
type
label
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@ast
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@en
prefLabel
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@ast
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@en
P2093
P2860
P356
P1476
The effect of anti-VEGF drugs ...... tatic colorectal cancer (mCRC)
@en
P2093
Binbin Cui
Guangliang Li
Haohao Wang
Kuifeng He
Lisong Teng
P2860
P356
10.2147/OTT.S29719
P407
P577
2012-04-13T00:00:00Z